Relapse

Patients with myelofibrosis who cleared driver mutations within 30 days after hematopoietic stem cell transplantation survived longer and exhibited reduce risk for relapse, according to study results.

Researchers have identified additional predictors of relapse in patients undergoing liver transplant for alcohol-related liver disease, including younger age and prior relapse, which differ from components of current prediction scores.

Tapering tocilizumab leads to a longer relapse-free period in patients with giant cell arteritis, compared with abrupt discontinuation, according to data published in Seminars in Arthritis and Rheumatism.

Glucocorticoids are an effective go-to treatment for giant cell arteritis, but discontinuing them can be difficult, according to a presenter at the 2024 AWIR annual conference.

Higher scores on a measure of sinonasal symptoms can predict ANCA-associated vasculitis relapse “months to years” ahead of time, according data published in Arthritis Care & Research.

DENVER – For older adults with MS and signs of cancer, treatment with immune checkpoint inhibitors was safe and prevented relapse or disease progression, according to interim research.

Treatment with evobrutinib in continuous, twice-daily dosing provided the lowest relapse rate and highest arrest of clinical worsening after 5 years in those with relapsing multiple sclerosis, according to data presented at ECTRIMS 2023.

Cryotherapy may lower disease relapse in patients with alopecia areata compared with intralesional corticosteroid injections or topical steroids, according to a study.

Existing treatments for patients with an ultrahigh risk of psychosis offer relatively poor responsiveness, underscoring a need for further innovation in relapse prevention, according to a study published in JAMA Psychiatry.

Consuming a pro-inflammatory diet was associated with higher risk for relapse and greater FLAIR lesion volume in the periventricular region in adults with MS, according to research in the Multiple Sclerosis Journal.